WGS GeneDx Holdings Corp.
Healthcare$49.44+4.50%ClosedMarket Cap: $1.47B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.46
P/S
3.17
EV/EBITDA
-30.49
DCF Value
$-165.40
FCF Yield
-2.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
68.3%
Operating Margin
-7.7%
Net Margin
-17.6%
ROE
-27.5%
ROA
-15.4%
ROIC
-8.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $102.3M | 66.7% | $-26.2M | $-63.3M | $— | — |
| Q4 null | $121.0M | 65.2% | $-13.7M | $-17.7M | $— | — |
| FY null | $427.5M | 69.7% | $-11.8M | $-21.0M | $— | — |
| Q3 null | $116.7M | 72.4% | $-3.3M | $-7.6M | $— | — |
| Q2 null | $102.7M | 69.0% | $9.0M | $10.8M | $— | — |
| Q1 null | $87.1M | 67.1% | $-4.6M | $-6.5M | $— | — |
| Q4 null | $95.6M | 69.2% | $8.8M | $5.4M | $— | — |
| FY null | $305.4M | 63.6% | $-23.2M | $-52.3M | $— | — |
| Q3 null | $76.9M | 62.2% | $-7.8M | $-8.3M | $— | — |
| Q2 null | $70.5M | 60.9% | $-10.6M | $-29.2M | $— | — |
| Q1 null | $62.4M | 59.9% | $-13.7M | $-20.2M | $— | — |
| Q4 2023 | $57.4M | 53.6% | $-25.6M | $-25.8M | $-0.99 | — |